Compare SER & GIFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SER | GIFT |
|---|---|---|
| Founded | 2017 | 1999 |
| Country | United States | United States |
| Employees | 16 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.0M | 39.0M |
| IPO Year | 2024 | 2019 |
| Metric | SER | GIFT |
|---|---|---|
| Price | $2.81 | $0.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 40.9K | ★ 70.4K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 52.05 |
| EPS | N/A | ★ N/A |
| Revenue | $130,000.00 | ★ $83,181,716.00 |
| Revenue This Year | N/A | $8.19 |
| Revenue Next Year | N/A | $10.30 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 132.14 | N/A |
| 52 Week Low | $1.22 | $0.73 |
| 52 Week High | $7.92 | $1.29 |
| Indicator | SER | GIFT |
|---|---|---|
| Relative Strength Index (RSI) | 74.64 | 49.06 |
| Support Level | $1.74 | $0.81 |
| Resistance Level | $2.99 | $1.11 |
| Average True Range (ATR) | 0.16 | 0.07 |
| MACD | 0.07 | -0.00 |
| Stochastic Oscillator | 90.91 | 24.11 |
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.
Giftify Inc operates in the incentive and rewards industry with a focus on retail, dining, and entertainment experiences, as the owner and operator of digital platforms, CardCash.com, Restaurant.com, and Takeout7.com. CardCash.com is a secondary gift card exchange platform, allowing consumers and retailers to buy and sell gift cards at various scales from several retailers; Restaurant.com is a restaurant-focused digital deals brand, connecting digital consumers and businesses by offering dining, retail, and entertainment deal options at several restaurants and retailers; and Takeout7 is a restaurant technology company offering online ordering solutions and AI-powered digital marketing services. Giftify has one segment, the sale of gift cards and discount certificates to its customers.